Open Access 01-12-2022 | Graft-Versus-Host Disease | Research
Posaconazole oral suspension for secondary antifungal prophylaxis in allogeneic stem cell transplantation recipients: a retrospective study
Published in: BMC Infectious Diseases | Issue 1/2022
Login to get access